Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19)

Gayatri Narayanan, Monique Opuszcka Campos, Nolan Groninger, Heather N. Burney, Matthew Hays, Matthew Dollins, Eliott Arroyo, Arvin Halim, Yang Li, Syed Jawad Sher, Sharon Moe, Kenneth Lim

Open source

DOI
10.1590/2175-8239-jbn-2025-0377en
Published
2026
Container
Brazilian Journal of Nephrology
Publisher
FapUNIFESP (SciELO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1590/2175-8239-jbn-2025-0377en,
  title = {Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19)},
  author = {Gayatri Narayanan and Monique Opuszcka Campos and Nolan Groninger and Heather N. Burney and Matthew Hays and Matthew Dollins and Eliott Arroyo and Arvin Halim and Yang Li and Syed Jawad Sher and Sharon Moe and Kenneth Lim},
  year = {2026},
  journal = {Brazilian Journal of Nephrology},
  doi = {10.1590/2175-8239-jbn-2025-0377en},
  url = {https://doi.org/10.1590/2175-8239-jbn-2025-0377en}
}

RIS

TY  - JOUR
TI  - Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19)
AU  - Gayatri Narayanan
AU  - Monique Opuszcka Campos
AU  - Nolan Groninger
AU  - Heather N. Burney
AU  - Matthew Hays
AU  - Matthew Dollins
AU  - Eliott Arroyo
AU  - Arvin Halim
AU  - Yang Li
AU  - Syed Jawad Sher
AU  - Sharon Moe
AU  - Kenneth Lim
PY  - 2026
JO  - Brazilian Journal of Nephrology
DO  - 10.1590/2175-8239-jbn-2025-0377en
UR  - https://doi.org/10.1590/2175-8239-jbn-2025-0377en
ER  - 

APA

Narayanan, G., Campos, M. O., Groninger, N., Burney, H. N., Hays, M., Dollins, M., Arroyo, E., Halim, A., Li, Y., Sher, S. J., Moe, S., & Lim, K. (2026). Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19). Brazilian Journal of Nephrology. https://doi.org/10.1590/2175-8239-jbn-2025-0377en

Source records